VERACYTE, INC.·4

Sep 4, 5:13 PM ET

Febbo Phillip G. 4

4 · VERACYTE, INC. · Filed Sep 4, 2025

Insider Transaction Report

Form 4
Period: 2025-09-02
Febbo Phillip G.
Chief Scientific & Med Officer
Transactions
  • Tax Payment

    Common Stock

    2025-09-02$30.11/sh2,955$88,975100,790 total
Footnotes (1)
  • [F1]Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2025 and does not represent a sale.

Documents

1 file
  • 4
    wk-form4_1757020419.xmlPrimary

    FORM 4